| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |